Specialized Manufacturing Elge, Inc. specializes in private label pharmaceutical manufacturing, producing a diverse range of products such as creams, liquids, ointments, suppositories, and suspensions, including OTC and DEA-controlled substances, indicating potential opportunities to supply custom formulations or expand product line collaborations.

Growth and Revenue With an estimated revenue between 10 million and 25 million dollars, Elge shows steady financial stability, signaling a capacity for growth partnerships or technology upgrades to enhance production efficiency and product innovation.

Industry Expertise Led by President Larry Gremminger, a seasoned pharmacist, Elge is deeply rooted in pharmaceutical manufacturing and active memberships in industry associations, making it a promising partner for compliance-enhanced solutions and industry-specific technology or process improvements.

Technology Stack Utilizing advanced management and production technologies including Telerik Sitefinity, Lua, Microsoft ASP.NET, OpenResty, and Nginx, Elge demonstrates openness to adopting innovative tech solutions, offering potential sales avenues for digital transformation or automation tools.

Market Position Operating within a competitive landscape alongside large multinational firms, Elge’s niche focus on private label and controlled substances positions it as a strategic partner for companies seeking high-quality, customizable pharmaceutical manufacturing solutions with commitment to quality and compliance.